PGAM1 and pachyonychia congenita: Similarly, phosphoglycerate mutase 1 (PGAM1), a key glycolytic protein, is significantly overexpressed in PC metastases and associated with poor prognosis 223, while the use of an allosteric PGAM1 inhibitor restrains PC progression 224.